Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

Inclusion Criteria: * Adults with early-stage mycosis fungoides (stages IA-IB) * At least two target lesions that have been present for at least 3 weeks and is at least 10 cm2 , so that at least one lesion may be allocated to each of the treatment regimes * Target lesion with swab that is culture positive for staphylococcus aureus, but not to an extent that would require systemic antibiotics * Agree to avoid washing or using a topical application at the target lesion starting the night before each scheduled study visit. * Agree for the duration of study participation to avoid using dilute bleach or vinegar baths, or other antiseptic use, at the target lesion from screening throughout the study. Exclusion Criteria: * Patients currently or recently (within past 4 weeks) on topical or systemic antibiotics adults unable to provide informed consent, (infants, children, teenagers, pregnant women, prisoners and other vulnerable populations.